ReviewJournal of thoracic disease2026
Echocardiography-based multimodal models for thromboembolic risk prediction in atrial fibrillation: a narrative review.
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: The congestive heart failure, hypertension, age ≥75 years, diabetes, stroke, vascular disease, age 65-74 years, sex category (CHA Methods: A comprehensive literature search was conducted using relevant electronic databases (e.g., PubMed, Web of Science and Embase) to identify studies focusing on echocardiographic parameters, AF, and thromboembolic risk prediction models published up to May 2026. Key Content and Findings: Echocardiographic parameters evaluating the left atrium and left atrial appendage (LAA; size, function, and morphology) have emerged as significant predictors of both prevalent thrombus formation and future thromboembolic events. This review details these key parameters and critically assesses various multimodal approaches, including those combining clinical-echocardiographic scores with artificial intelligence (AI) techniques. Importantly, these models demonstrate enhanced predictive accuracy for specific clinical endpoints over traditional clinical scores. Conclusions: Utilizing a multimodal approach provides a promising supplementary tool for refined risk assessment, rather than replacing guideline-based anticoagulation decisions. Future directions should focus on standardizing echocardiographic measurements, expanding the use of AI for automated analysis, and conducting prospective interventional trials to confirm clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.